Sign In
Buy ODYY
$0.0130
-0.0007 (-4.92%)
At Close: Jun 03, 2026
Odyssey Health, Inc. Secures Exclusive Global Distribution Rights for BreastCheck™ to Drive Recurring Revenue Growth
08:00am, Wednesday, 22'nd Apr 2026
Agreement Positions Company for Near-Term Revenue and Commercial Launch LAS VEGAS, April 22, 2026 /PRNewswire/ -- Odyssey Health, Inc. (OTCQB: ODYY), a medical device company focused on life-saving te
Odyssey Health, Inc. (OTCMKTS:ODYY) Short Interest Update
04:01am, Thursday, 12'th Feb 2026
Odyssey Health, Inc. (OTCMKTS:ODYY - Get Free Report) was the recipient of a significant increase in short interest in January. As of January 30th, there was short interest totaling 63,696 shares, an
Odyssey Health, Inc. Secures Multi-Million-Dollar, Nine-Year Service Contract and Financing Facility for Up to $25 Million
08:30am, Wednesday, 19'th Nov 2025
Service agreement and financing facility supports strategic growth and commercialization initiatives Service agreement and financing facility supports strategic growth and commercialization initiative
Odyssey Health, Inc., Enters the $26 Billion Breast Cancer Marketplace
08:30am, Thursday, 16'th Oct 2025
Odyssey Medical Devices, Inc., a subsidiary of Odyssey Health Inc., to acquire exclusive global marketing and distribution rights for the BreastCheck® Odyssey Medical Devices, Inc., a subsidiary of O
Odyssey Health, Inc. to Advance Development of its Save A Life Choking Rescue Device
08:30am, Tuesday, 26'th Aug 2025
LAS VEGAS, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTCQB: ODYY) (the “Company” or “Odyssey”), a technology and asset acquisition company focused on developing unique, life-savi
Odyssey Health, Inc. Strengthens Balance Sheet with $8.7 Million in Net Equity
08:30am, Wednesday, 27'th Mar 2024
LAS VEGAS, NV / ACCESSWIRE / March 27, 2024 / Odyssey Health, Inc. (OTCQB:ODYY), formerly Odyssey Group International, Inc., (the "Company") a company focused on developing unique, life-enhancing medi
LAS VEGAS, NV / ACCESSWIRE / January 2, 2024 / Odyssey Health, Inc. (OTCQB:ODYY) ("Odyssey" or the "Company") today announces the closing of the definitive Asset Purchase Agreement, that was entered i
Odyssey Health, Inc. Gains Shareholder Approval for Asset Sale with Oragenics, Inc.
08:30am, Tuesday, 12'th Dec 2023
LAS VEGAS, NV / ACCESSWIRE / December 12, 2023 / Odyssey Health, Inc. (OTCOB:ODYY), a company focused on developing unique, life-enhancing medical products including a drug treatment intended to treat
Odyssey Health, Inc, Selects Syneos Health to Support Investigational New Drug Application for Treatment of Concussion
08:30am, Thursday, 16'th Nov 2023
LAS VEGAS, NV / ACCESSWIRE / November 16, 2023 / Odyssey Health, Inc. (OTCQB:ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, ha
Odyssey Health, Inc. to Provide Company Update and Webcast for Shareholders
12:00pm, Wednesday, 15'th Nov 2023
LAS VEGAS, NV / ACCESSWIRE / November 15, 2023 / Odyssey Health, Inc. (OTCQB:ODYY), formerly Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products,
Odyssey Health, Inc. Provides Update on Asset Purchase Agreement with Oragenics, Inc.
08:30am, Wednesday, 18'th Oct 2023
LAS VEGAS, NV / ACCESSWIRE / October 18, 2023 / Odyssey Health, Inc. (OTCQB:ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products is p
Odyssey Health Inc. Begins Trading on the OTCQB
08:30am, Wednesday, 04'th Oct 2023
LAS VEGAS, NV / ACCESSWIRE / October 4, 2023 / Odyssey Health, Inc. (formerly known as Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), is a medical device and pharmaceutic
Odyssey Group International Files Patent On Novel Breath-Propelled Nasal Delivery Device
10:03am, Tuesday, 19'th Oct 2021
IRVINE, CA, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a medical technology company focused on developing unique, life-saving medic
Odyssey Group International Begins Enrolling Subjects for Phase 1 Clinical Trial to Treat Concussion
08:39am, Wednesday, 22'nd Sep 2021
IRVINE, CA, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC: ODYY ) (the "Company" or "Odyssey"), a medical company focused on developing unique, life-saving medical products
Odyssey Group International Approved to Start Human Trial to Treat Concussion
08:30am, Wednesday, 01'st Sep 2021
IRVINE, CA, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC: ODYY ) (the "Company" or "Odyssey"), a company focused on developing unique, life-saving medical products, today
